Nanomedicine News

RSS

Graphene Strip Flying Carpets Deliver Two Anticancer Drugs Sequentially

An international team of researchers has developed a drug delivery technique that utilizes graphene strips as “flying carpets” to deliver two anticancer drugs sequentially to cancer cells, with each drug targeting the distinct part of the cell where it will be most effective. The technique was found to perform better than either drug in isolation when tested in a mouse model targeting a human lung cancer tumor.

7 Jan 2015

Celsion Submits Phase I Clinical Trial Protocol for GEN-1 DNA-Based Immunotherapy with Nanoparticle Delivery System

Celsion Corporation (Celsion), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies for the treatment of cancer and other difficult-to-treat diseases, today announced the submission of its Phase I clinical trial protocol to the U.S. Food and Drug Administration (FDA) for GEN-1, the Company's DNA-based immunotherapy for the localized treatment of cancer.

7 Jan 2015

OSU's New System Using Nanoparticles Can Improve Cancer Surgery, Phototherapy

Researchers at Oregon State University have developed a new way to selectively insert compounds into cancer cells - a system that will help surgeons identify malignant tissues and then, in combination with phototherapy, kill any remaining cancer cells after a tumor is removed.

6 Jan 2015

IND Submitted to CFDA for STP705 Anti-Fibrosis RNAi to Treat Human Skin Hypertrophic Scars

Sirnaomics, Inc. and its affiliate Suzhou Sirnaomics Pharmaceutics, Co. Ltd.,, together with its partner Guangzhou Xiangxue Pharmaceutical, Co. Ltd., have formally submitted an Investigational New Drug (IND) Application to the China Food and Drug Administration (CFDA) for STP705, an anti-fibrosis RNA interference (RNAi) therapeutic for prevention and treatment of human skin hypertrophic scars.

5 Jan 2015

Tekmira Completes Enrolment in TKM-PLK1 Phase I/II Clinical Study in Advanced GI-NET and ACC

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today provided a status update on the Phase I/II clinical study in patients with advanced Gastrointestinal Neuroendocrine Tumors (GI-NET) and Adrenocortical Carcinoma (ACC).

2 Jan 2015

Researchers Combine Antioxidant Biomaterials with Calcium Nanocrystals to Create Bone-Like Material

Connecting the femur to the tibia, the anterior cruciate ligament (ACL) rupture is one of the most devastating injuries in sports. No other injury has sidelined more athletes for a season or even the rest of a career.

31 Dec 2014

Tekmira to Provide TKM-Ebola-Guinea Therapeutic Product for Clinical Studies in Africa

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today that the Company has entered into a Manufacturing and Clinical Trial Agreement with the University of Oxford to provide the new TKM-Ebola-Guinea therapeutic product for clinical studies in West Africa. The studies are expected to commence early next year, subject to finalization of a suitable clinical protocol.

23 Dec 2014

MRI Probe Pairs Magnetic Nanostructure with Antibody for Early Detection of Alzheimer's Disease

No methods currently exist for the early detection of Alzheimer's disease, which affects one out of nine people over the age of 65. Now, an interdisciplinary team of Northwestern University scientists and engineers has developed a noninvasive MRI approach that can detect the disease in a living animal. And it can do so at the earliest stages of the disease, well before typical Alzheimer's symptoms appear.

23 Dec 2014

Alternative Energy & Environmental Solutions Enters LoI to Acquire BioTechPharma

Alternative Energy & Environmental Solutions, Inc., today announced that it has signed a letter of intent to acquire BioTechPharma Corporation, a biotechnology company that has developed and patented a nanotechnology...

23 Dec 2014

ORNL Researchers Discover Technique for Increasing Binding Strength and Selectivity of Crown Ether Molecules

A research team led by the Department of Energy’s Oak Ridge National Laboratory have found a technique to drastically increase the binding strength and selectivity of crown ethers.

From Oak Ridge National Laboratory 22 Dec 2014

Nanomedicine News

Graphene Strip Flying Carpets Deliver Two Anticancer Drugs Sequentially

Celsion Submits Phase I Clinical Trial Protocol for GEN-1 DNA-Based Immunotherapy with Nanoparticle Delivery System

OSU's New System Using Nanoparticles Can Improve Cancer Surgery, Phototherapy

IND Submitted to CFDA for STP705 Anti-Fibrosis RNAi to Treat Human Skin Hypertrophic Scars

Tekmira Completes Enrolment in TKM-PLK1 Phase I/II Clinical Study in Advanced GI-NET and ACC

Researchers Combine Antioxidant Biomaterials with Calcium Nanocrystals to Create Bone-Like Material

Tekmira to Provide TKM-Ebola-Guinea Therapeutic Product for Clinical Studies in Africa

MRI Probe Pairs Magnetic Nanostructure with Antibody for Early Detection of Alzheimer's Disease

Alternative Energy & Environmental Solutions Enters LoI to Acquire BioTechPharma

ORNL Researchers Discover Technique for Increasing Binding Strength and Selectivity of Crown Ether Molecules

Magnetic Nanocarbon Composite Cleans Chernobyl’s Wastewater

Double-Layer Design Boosts Charge and Range of EV Batteries

Dark Nanoparticles Make Kidney Stone Removal Faster and Safer

Innovative Nanoparticle Technology Promises Long-Lasting Protection for Dental Restorations

Nano-Biochar Converts Toxic Silver Ions into Stable Nanoparticles within Rice Plants

Enhancing Slurry Stability in Lithium-Ion Batteries with Turbiscan Technology

PiFM and its Role in Nanoscale Chemical Imaging

Conversations on AFM: How AI is Automating Scanning Probe Microscopy

Most Read Articles

1What is Transmission Electron Microscopy and How is it Used in Nano?

2Parallel Alignment Strategies for Complex Photonics Devices

3How is Nanoscience Solving Our Environmental Problems?

4What are Zero-Dimensional Nanomaterials?

5DNA Origami: How This Nanotechnology Could Advance Medicine

6Using SEM for Structural Analysis in Nanomaterials

Sponsored Content

Parallel Alignment Strategies for Complex Photonics Devices

Advancing Electron Microscopy Research

Mapping Phonons in Nanostructures for Thermal Engineering

Scaling High-Pressure Homogenization with Genizer